Hepatitis A, B, and C Prevention Programs
Information and Programs for People at Risk
 
  Home
  Hep Express archives
    Search
 

Prevention Programs

  APIA programs
  Corrections, adult
  Corrections, juvenile
  Family planning
  Harm reduction
  Homeless programs
  MSM
  Perinatal related
  School programs
  STD/HIV
  Other programs
  Index of programs
    Support Group Info
  Hepatitis B
  Hepatitis C
  Listed by state
    Hepatitis B Info
  FAQ about hep B
  VISs
  Laws and mandates
  Case histories
  Photos
  Videos
    Hepatitis A Info
  FAQ about hep A
  VISs
  Laws and mandates
  Case histories
  Photos
    Hep-related Topics
  International adoption
  Tattooing and piercing
  Travel vaccination
  Healthcare workers
  Needle safety
  Dialysis
    Other Information
  CDC website
  Hep organizations
  NASTAD website
  Contact NASTAD
  About NASTAD
  Privacy policy
 

(click on the image)


Hep Express Issue 18

Issue Number 18, June 25, 2004
 
Contents of this Issue
1. CDC made great strides in viral hepatitis prevention under the leadership of Dr. Harold Margolis
2. AMA develops guide to appropriate reimbursement coding for populations at risk of viral hepatitis
3. CDC publishes state hepatitis C prevention activities on its website
4. Web-text versions of IAC's standing orders protocols can be modified to meet your practice or clinic needs
5. Errors discovered and corrected in footnotes of "Recommended Childhood and Adolescent Immunization Schedule--United States, July-December 2004" on the NIP website
6. CDC offers web-based hepatitis B disease burden model
7. IAC publishes updated education piece on unusual cases of HBV transmission
8. Centerforce to host 5th Annual Inside/Out Summit in San Francisco, September 11-15
9. Therapies for Viral Hepatitis workshop to be held November 2-3 in Boston
10. Coming soon! HFI'S National Viral Hepatitis Summit scheduled for August 26-27 in Baltimore, MD
11. Continuing education: For a global immunization perspective, subscribe to these high-quality international listservs

ABBREVIATIONS: ACIP, Advisory Committee on Immunization Practices; CDC, Centers for Disease Control and Prevention; DVH, Division of Viral Hepatitis; HAV, hepatitis A virus; HBV, hepatitis B virus; HCV, hepatitis C virus; IAC, Immunization Action Coalition; IDU, injection drug user; MMWR, Morbidity and Mortality Weekly Report; MSM, men who have sex with men; STD, sexually transmitted disease; VIS, Vaccine Information Statement; WHO, World Health Organization.
----------------------------------------------------------------

(1 of 11)
June 25, 2004
CDC MADE GREAT STRIDES IN VIRAL HEPATITIS PREVENTION UNDER THE LEADERSHIP OF DR. HAROLD MARGOLIS

[The following is cross posted from the Immunization Action Coalition's "IAC EXPRESS" electronic newsletter, 6/21/04.]

In April, CDC announced that Harold S. Margolis, MD, will be retiring on June 30 from his position as director, Division of Viral Hepatitis. Dr. Margolis will become the director of the Pediatric Dengue Vaccine Initiative in Seoul, Korea. Before moving to Seoul, he will work at the Emory Vaccine Center in Atlanta.

Dr. Margolis began his career with CDC in 1975 as an EIS (Epidemic Intelligence Service) officer, Alaska Investigation Division, Anchorage. In 1981, he transferred to the Division of Hepatitis and Viral Enteritis, Phoenix. In 1987, he became the chief, Hepatitis Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases. Under his outstanding leadership, and with his vision and tireless effort, the Division of Viral Hepatitis was created in 2001, and he was appointed director. He is also the director of WHO's Collaborating Center for Reference and Research on Viral Hepatitis.

In his 29-year career with CDC, Dr. Margolis has made significant contributions to viral hepatitis prevention. Following is information provided by CDC:

**********************

The impact of Dr. Margolis's scientific achievements is especially evident in the area of hepatitis B virus prevention. He was the architect of the national Hepatitis B Elimination Strategy, and under his direction, both perinatal and universal childhood immunization have been successfully implemented. These activities have successfully reduced transmission among infants and young children by 70%-80%. This elimination strategy is a model for vaccination programs worldwide. In addition to supporting global hepatitis B immunization activities, Dr. Margolis was instrumental in setting up the Safe Injection Global Network at WHO in recognition of the need to direct efforts to prevent health care related transmission of bloodborne pathogens through unsafe injections. Dramatic achievements in the reduction of hepatitis A through immunization also have been realized during Dr. Margolis's tenure, and he is responsible for overseeing the National Hepatitis C Prevention Strategy, and for bringing attention and resources to the prevention of an important chronic disease of infectious etiology.

Dr. Margolis's scientific accomplishments and leadership skills have brought him respect throughout the scientific community, both nationally and internationally. He has been invited to testify before the U.S. Congress and state legislatures; to serve as a consultant to the World Health Organization; to sit on numerous review panels; to serve as an advisor to the National Institutes of Health Committee on Digestive Diseases; and to chair workshops and symposia at national and international programs. In 2000, he hosted the 10th international Symposium on Viral Hepatitis and Liver Disease. During Dr. Margolis's tenure at CDC he has served in a number of additional capacities including senior advisor, Smallpox Preparedness and Response, Office of the Director, CDC (2001-2002).

**********************

In commenting on Dr. Margolis's retirement, IAC executive director Dr. Deborah Wexler reflected on him as a colleague and leader. "Hal is a dear friend," she said. "He's engaging, stimulating, and challenging. He's also been a mentor: With his encyclopedic knowledge of viral hepatitis, he's definitely THE source to seek for information. Hal is also a visionary who has developed innovative strategies about how public health agencies, such as hepatitis, STD, HIV, and immunization, can work together to achieve viral hepatitis elimination. Replacing him as director of the Division of Viral Hepatitis will be a daunting task."
----------------------------------------------------------------
Return to top

(2 of 11)
June 25, 2004
AMA DEVELOPS GUIDE TO APPROPRIATE REIMBURSEMENT CODING FOR POPULATIONS AT RISK OF VIRAL HEPATITIS

The American Medical Association (AMA) has joined with CDC to help protect MSM and other at-risk individuals from HBV and HAV infection. On March 8, 2004, four CDC divisions released a "Dear Colleague" letter urging health care professionals to help prevent STDs among MSM. At the same time, CDC launched a section of related online resources at http://www.cdc.gov/ncidod/diseases/hepatitis/msm

In order to complement this program and assist physicians in implementing this call to action, the AMA created a trifold pocket guide to appropriate reimbursement coding for immunizing populations at risk against hepatitis B and hepatitis A. You can download "Coding Guidelines for Vaccine-Preventable Hepatitis (VPH)" at
http://www.ama-assn.org/ama1/pub/upload/mm/36/ama_hep_coding_trifo.pdf

A hotline phone number is also available for answers about reimbursement on a patient-by-patient basis: (888) 822-2749. GlaxoSmithKline underwrites this service; information is given regardless of the vaccine used.
----------------------------------------------------------------
Return to top

(3 of 11)
June 25, 2004
CDC PUBLISHES STATE HEPATITIS C PREVENTION ACTIVITIES ON ITS WEBSITE

CDC's Division of Viral Hepatitis has published the strategic plans for prevention and control of hepatitis C from 11 states on its website. These plans provide a road map for prioritizing the development of prevention activities, integrating hepatitis prevention activities into existing public health programs, and obtaining resources to achieve implementation activities.

Others may find these plans to be useful when developing their own locale's hepatitis C prevention strategy. To access the plans listed by state, go to:
http://www.cdc.gov/ncidod/diseases/hepatitis/partners/state_plans.htm
---------------------------------------------------------------
Return to top

(4 of 11)
June 25, 2004
WEB-TEXT VERSIONS OF IAC'S STANDING ORDERS PROTOCOLS CAN BE MODIFIED TO MEET YOUR PRACTICE OR CLINIC NEEDS

Intended to help increase adult immunization rates, standing orders protocols are guidelines health professionals can use to allow appropriately licensed individuals to administer vaccines without a physician's direct order.

In the past year, IAC has developed eight standing orders protocols for administering vaccine to adults. Besides being available as ready-to-copy (PDF) documents, these pieces are now available in web-text (HTML) format on IAC's website. The advantage of providing these documents in HTML format is that it allows providers to cut, paste, and modify these protocols to create ones that meet the needs of their practice or clinic.

Only the links to standing orders protocols for hepatitis A and hepatitis B administration are provided below. You can download standing orders protocols for additional vaccines from IAC's online catalog at http://www.immunize.org/free

To access the web-text (HTML) version of "Standing Orders for Administering Hepatitis A Vaccine to Adults," go to:
http://www.immunize.org/catg.d/p3077.htm

To access the web-text (HTML) version of "Standing Orders for Administering Hepatitis B Vaccine to Adults," go to:
http://www.immunize.org/catg.d/p3076.htm

If you wish to use the PDF versions of these standing orders (which are ready-to-copy from any browser, but not alterable), go to:

"Standing Orders for Administering Hepatitis A Vaccine to Adults"
http://www.immunize.org/catg.d/p3077.pdf

"Standing Orders for Administering Hepatitis B Vaccine to Adults"
http://www.immunize.org/catg.d/p3076.pdf
----------------------------------------------------------------
Return to top

(5 of 11)
June 25, 2004
ERRORS DISCOVERED AND CORRECTED IN FOOTNOTES OF "RECOMMENDED CHILDHOOD AND ADOLESCENT IMMUNIZATION SCHEDULE—UNITED STATES, JULY-DECEMBER 2004" ON THE NIP WEBSITE

The National Immunization Program (NIP) discovered several errors in the footnotes of "Recommended Childhood and Adolescent Immunization Schedule--United States, July-December 2004" as originally published on the NIP website, primarily with the influenza vaccine footnote.

If you downloaded the new schedule from the NIP website prior to May 28, you should not reproduce or distribute this version of the schedule. The incorrect files have been removed, and corrected versions have been posted on the NIP website.

To access the corrected and reposted "Recommended Childhood and Adolescent Immunization Schedule--United States, July-December 2004," from the NIP website, go to: http://www.cdc.gov/nip/recs/child-schedule.htm#Printable Scroll down to the section titled "July-December 2004 New!" and select the version you want.

The version of the schedule printed in the April 30 issue of "MMWR Quick Guide," in "Pediatrics," and on IAC's website is correct. To access the correct "Recommended Childhood and Adolescent Immunization Schedule—United States, July-December 2004" from IAC's website, go to: http://www.immunize.org/cdc/child-schedule.pdf
---------------------------------------------------------------
Return to top

(6 of 11)
June 25, 2004
CDC OFFERS WEB-BASED HEPATITIS B DISEASE BURDEN MODEL

CDC has developed a computer model to help assess the hepatitis B disease burden in any country. Given just a few data points, the model will calculate a country's current and future hepatitis B disease burden. It will also project the reduction in burden that could be realized with different hepatitis B vaccination strategies.

The model is available on the Advanced Immunization Management (AIM) website. To access this resource, go to:
http://www.cdc.gov/ncidod/diseases/hepatitis/model.htm
---------------------------------------------------------------
Return to top

(7 of 11)
June 25, 2004
IAC PUBLISHES UPDATED EDUCATION PIECE ON UNUSUAL CASES OF HBV TRANSMISSION

In June, IAC published an education piece titled "Unusual Cases of Hepatitis B Virus Transmission." This piece replaces the 1994 article "No Risk?? No Way!!"

The updated document may be useful to both health professionals and selected members of the public. It was developed to respond to parents who question the necessity of vaccinating infants against HBV because they believe that only sexually promiscuous persons or drug users could ever become infected with the virus. The piece presents 21 scenarios of HBV transmission via medical procedures, team sports, day care, school, and more. All cases were reported in peer-reviewed journals and citations are provided.

"Unusual Cases of Hepatitis B Virus Transmission" is available in ready-to-copy (PDF) format at
http://www.immunize.org/catg.d/p2100nrs.pdf
-------------------------------------------------------------
Return to top

(8 of 11)
June 25, 2004
CENTERFORCE TO HOST 5TH ANNUAL INSIDE/OUT SUMMIT IN SAN FRANCISCO, SEPTEMBER 11-15

Centerforce is hosting its 5th Annual Inside/Out Summit, "Models for Change—Delivering Services to Those Affected by Incarceration" in San Francisco, CA, September 11-15, 2004.

Centerforce provides services for prisoners, ex-prisoners, and family members of prisoners through direct services, an annual conference, and through consultation and training for government agencies, community-based organizations, and correctional facilities across the country and internationally.

For more information about the Summit, visit Centerforce at http://www.centerforce.org/summit or call Beth Houghton at (415) 456-9980, extension 124.
-------------------------------------------------------------
Return to top

(9 of 11)
June 25, 2004
THERAPIES FOR VIRAL HEPATITIS WORKSHOP TO BE HELD NOVEMBER 2-3 IN BOSTON

The Therapies for Viral Hepatitis workshop will be held November 2-3, 2004, in Boston, MA. This international meeting provides an opportunity to address the clinical development of treatment of viral hepatitis. The meeting will be held immediately after the American Association for the Study of Liver Disease (AASLD) meeting.

The deadline for both abstract submission and early-bird registration is August 20, 2004.

For information on the workshop agenda or registration, go to:
http://www.intmedpress.com/hepatitis
-------------------------------------------------------------
Return to top

(10 of 11)
June 25, 2004
COMING SOON! HFI'S NATIONAL VIRAL HEPATITIS SUMMIT SCHEDULED FOR AUGUST 26-27 IN BALTIMORE, MD

The Third Annual National Viral Hepatitis Summit will be held
August 26-27, 2004, in Baltimore, MD. The conference is sponsored by Hepatitis Foundation International (HFI) and is intended for physicians, nurses, psychologists, counselors, outreach workers, patient advocates, and others working with people who are affected by or infected with viral hepatitis.

For information about the agenda and/or registration, go to http://www.hepfi.org/pdfs/registrationsummit.pdf or call (800) 891-0707.
-------------------------------------------------------------
Return to top

(11 of 11)
June 25, 2004
CONTINUING EDUCATION: FOR A GLOBAL IMMUNIZATION PERSPECTIVE, SUBSCRIBE TO THESE HIGH-QUALITY INTERNATIONAL LISTSERVS

[The following is cross posted from the Immunization Action Coalition's "IAC EXPRESS" electronic newsletter, 6/21/04.]

For an understanding of global public health issues, including immunization and viral hepatitis, you might want to subscribe to one or more international listservs. IAC regards the ones below as among the best.

SIGNpost (a publication of the Safe Injection Global Network [SIGN]). Created by WHO, SIGN is a comprehensive resource on international injection safety issues. To subscribe to SIGNpost, a weekly moderated email forum, go to: http://www.who.int/injection_safety/newsletter/SIGNPost Fill in the subscription information requested at the bottom of the screen. You can visit SIGN's home page at http://www.who.int/injection_safety

Weekly Epidemiological Record (a WHO publication). Communicates epidemiological information on cases and outbreaks of diseases under the International Health Regulations and on other communicable diseases of public health importance. To subscribe, send a message to majordomo@who.ch Leave the subject line blank, and type "subscribe wer-reh" in the body of the message.

VHPB email service (a publication of the Viral Hepatitis Prevention Board [VHPB]). The objective of VHPB is to contribute to the control and prevention of viral hepatitis by drawing attention to viral hepatitis, issuing prevention guidelines, and encouraging actions to improve control and prevention. The email service contains current information from the VHPB website and the organization's newsletter, "Viral Hepatitis." To subscribe, go to: http://www.vhpb.org Click on "VHPB e-mail service" in the left column.

ProMED-digest (a publication of the International Society of Infectious Diseases). Publishes updates on disease outbreaks around the world several times a week. To subscribe, go to:
http://www.isid.org/promedmail/subscribe.lasso


Nastad
www.nastad.org
nastad@nastad.org
          Hepatitis Prevention Programs
www.hepprograms.org
nastad@nastad.org

444 North Capitol Street, NW • Suite 339 • Washington D.C. 20001 • (202) 434-8090